Nuvectis Historical Valuation

NVCT Stock  USD 6.74  0.37  5.81%   
Some fundamental drivers such as market cap or Nuvectis Pharma enterprice value can be analyzed from historical perspective to project value of the company into the future. Some investors analyze Nuvectis Pharma valuation indicators such as to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of Nuvectis Pharma's future value.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nuvectis Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For more information on how to buy Nuvectis Stock please use our How to Invest in Nuvectis Pharma guide.

About Nuvectis Valuation Data Analysis

Valuation is the financial process of determining what Nuvectis Pharma is worth. Nuvectis Pharma valuation ratios put that insight into the context of a company's share price, where they serve as useful tools for evaluating and utilizing investment potential. Nuvectis Pharma valuation ratios help investors to determine whether Nuvectis Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nuvectis with respect to the benefits of owning Nuvectis Pharma security.

Nuvectis Pharma Valuation Data Chart

Market Cap is likely to drop to about 61.5 M in 2025. Enterprise Value is likely to drop to about 52.5 M in 2025

Enterprise Value

Enterprise Value (or EV) is usually referred to as Nuvectis Pharma theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Nuvectis Pharma debt, but would also pocket its cash. Enterprise Value is more accurate representation of Nuvectis Pharma value than its market capitalization because it takes into account all of Nuvectis Pharma existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Nuvectis Stock Analysis

When running Nuvectis Pharma's price analysis, check to measure Nuvectis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nuvectis Pharma is operating at the current time. Most of Nuvectis Pharma's value examination focuses on studying past and present price action to predict the probability of Nuvectis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nuvectis Pharma's price. Additionally, you may evaluate how the addition of Nuvectis Pharma to your portfolios can decrease your overall portfolio volatility.